EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RPARP‐AS1 Targets miR‐10b‐5p to Influence Prognosis in Non‐Small Cell Lung Cancer and Inhibit Tumor Progression

Conghui Wang iD, Jing Zhang iD, Xin Wang iD, Jianzhu Yang iD, Zhenlong Zhu iD, Ruoshi Yuan iD, Duojun Qiu iD

Analytical Cellular Pathology · 2026

DOI: 10.1155/ancp/8817867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Cellular Pathology, 2026. Verfasst von Conghui Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Hospital of Hebei Medical University, Shijiazhuang, 050023, China, hebmu.edu.cn. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Disease Progression. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province Medical Science Research Key Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the roles of RPARP‐AS1 and miR‐10b‐5p in regulating the prognosis and tumor progression of non‐small cell lung cancer (NSCLC).

Methods

A total of 138 NSCLC patients were enrolled. Surgical specimens were stored in liquid nitrogen. All patients received 5 years of clinical follow‐up for prognostic assessment. In addition, multivariate Cox regression analysis was conducted to identify independent factors affecting NSCLC prognosis, and gene expression levels were quantified by reverse transcription quantitative polymerase chain reaction (RT‐qPCR). Cell Counting Kit‐8 (CCK‐8) assays were performed to examine cell proliferation, and transwell assays were used to assess cell migration and invasion. Furthermore, nuclear‐cytoplasmic fractionation experiments were conducted to localize RPARP‐AS1 distribution. The interaction between RPARP‐AS1 and miR‐10b‐5p was examined by dual luciferase reporter assays, and downstream targets in NSCLC were predicted using databases.

Results

RPARP‐AS1 was downregulated, while miR‐10b‐5p was upregulated in both NSCLC patient tissues and cells. Patients with reduced RPARP‐AS1 expression or increased miR‐10b‐5p expression had lower survival rates, accompanied by worsened tumor size, differentiation, and metastasis. oe‐RPARP‐AS1 inhibited tumor cell proliferation, migration, and invasion. However, RPARP‐AS1‐induced functional alterations in NSCLC cells were mediated by miR‐10b‐5p. A total of 47 overlapping genes were identified to potentially mediate downstream signaling pathways of the RPARP‐AS1/miR‐10b‐5p axis in NSCLC cells.

Conclusion

Silencing RPARP‐AS1 targeted miR‐10b‐5p to induce NSCLC cell proliferation, migration, and invasion, leading to tumor progression and poor prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCarcinoma, Non-Small-Cell LungLung NeoplasmsDisease ProgressionRNA, AntisenseHumansFemalePrognosisGene Expression Regulation, NeoplasticCell ProliferationCell MovementMaleMiddle AgedCell Line, TumorNeoplasm Invasiveness

Stichwörter der Autor:innen

RPARP-AS1miR-10b-5pnon-small cell lung cancerprognosisprogression

Substanzen

MicroRNAsMIRN10 microRNA, humanRNA, Antisense

Autor:innen und Institutionen

  • Department of Pathology, The First Hospital of Hebei Medical University, Shijiazhuang, 050023, China, hebmu.edu.cn.

ORCID-Profile: Conghui Wang, Jing Zhang, Xin Wang, Jianzhu Yang, Zhenlong Zhu, Ruoshi Yuan, Duojun Qiu

Förderung

  • Hebei Province Medical Science Research Key Project

Zitieren

APA

Wang, C., Zhang, J., Wang, X., Yang, J., Zhu, Z., Yuan, R., & Qiu, D. (2026). RPARP‐AS1 Targets miR‐10b‐5p to Influence Prognosis in Non‐Small Cell Lung Cancer and Inhibit Tumor Progression. Analytical Cellular Pathology. https://doi.org/10.1155/ancp/8817867

Vancouver

Wang C, Zhang J, Wang X, Yang J, Zhu Z, Yuan R, et al. RPARP‐AS1 Targets miR‐10b‐5p to Influence Prognosis in Non‐Small Cell Lung Cancer and Inhibit Tumor Progression. Analytical Cellular Pathology. 2026. doi:10.1155/ancp/8817867

BibTeX
@article{Wang2026,
  author = {Wang, Conghui and Zhang, Jing and Wang, Xin and Yang, Jianzhu and Zhu, Zhenlong and Yuan, Ruoshi and Qiu, Duojun},
  title = {RPARP‐AS1 Targets miR‐10b‐5p to Influence Prognosis in Non‐Small Cell Lung Cancer and Inhibit Tumor Progression},
  journal = {Analytical Cellular Pathology},
  year = {2026},
  doi = {10.1155/ancp/8817867}
}
Kostenlos starten →